Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesClonazepam Withdrawal-Induced Catatonia
Psychosomatics, 07/14/09
Brown M et al. - Catatonia may result from a wide variety of etiologies. Catatonia due to benzodiazepine-withdrawal is a rare but serious condition that may be difficult to distinguish from other causes of catatonia. The mechanism by which catatonia may be precipitated by benzodiazepine-withdrawal is unknown, but likely involves a rapid decrease in GABA transmission in the central nervous system.
Related Articles
Electroconvulsive Therapy for Malignant Catatonia in Adolescence
Southern Medical Journal, 11/10/09
Relevance Score: 89%
Malignant Catatonia in a Patient with Bipolar Disorder, B12 Deficiency, and Neuroleptic Malignant Syndrome: One Cause or Three
Journal of Psychiatric Practice, 10/01/09
Relevance Score: 87%
The Catatonia Syndrome: Forgotten but Not Gone
Archives of General Psychiatry, 11/06/09
Relevance Score: 85%
The Catatonia Conundrum: Evidence of Psychomotor Phenomena as a Symptom Dimension in Psychotic Disorders
Schizophrenia Bulletin, 10/05/09
Relevance Score: 83%
New bipolar disorder research from Medical University of South Carolina described
Internet Source, 11/10/09
Relevance Score: 80%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Core Evidence, 12/11/09
Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/09/09
Complications and side-effects of foam sclerotherapy
Phlebology, 12/09/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid
Multiple Sclerosis, 12/11/09
Behavioral Dimensions and Acetylcholinesterase Inhibitor-related Effect in Alzheimer Disease Over Time: A Latent Trajectory Modeling
Cognitive and Behavioral Neurology, 12/11/09
Depression in Parkinson's Disease
Canadian Journal of Neurological Sciences, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor